These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19735987)

  • 1. Hereditary spastic paraplegia and axonal motor neuropathy caused by a novel SPG3A de novo mutation.
    Fusco C; Frattini D; Farnetti E; Nicoli D; Casali B; Fiorentino F; Nuccitelli A; Giustina ED
    Brain Dev; 2010 Aug; 32(7):592-4. PubMed ID: 19735987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary spastic paraplegia associated with axonal neuropathy: a novel mutation of SPG3A in a large family.
    Al-Maawali A; Rolfs A; Klingenhaeger M; Yoon G
    J Clin Neuromuscul Dis; 2011 Mar; 12(3):143-6. PubMed ID: 21321493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus.
    Sauter SM; Engel W; Neumann LM; Kunze J; Neesen J
    Hum Mutat; 2004 Jan; 23(1):98. PubMed ID: 14695538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy.
    Rainier S; Sher C; Reish O; Thomas D; Fink JK
    Arch Neurol; 2006 Mar; 63(3):445-7. PubMed ID: 16533974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia.
    Dürr A; Camuzat A; Colin E; Tallaksen C; Hannequin D; Coutinho P; Fontaine B; Rossi A; Gil R; Rousselle C; Ruberg M; Stevanin G; Brice A
    Arch Neurol; 2004 Dec; 61(12):1867-72. PubMed ID: 15596607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years.
    Namekawa M; Ribai P; Nelson I; Forlani S; Fellmann F; Goizet C; Depienne C; Stevanin G; Ruberg M; Dürr A; Brice A
    Neurology; 2006 Jan; 66(1):112-4. PubMed ID: 16401858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary spastic paraplegia 3A associated with axonal neuropathy.
    Ivanova N; Claeys KG; Deconinck T; Litvinenko I; Jordanova A; Auer-Grumbach M; Haberlova J; Löfgren A; Smeyers G; Nelis E; Mercelis R; Plecko B; Priller J; Zámecník J; Ceulemans B; Erichsen AK; Björck E; Nicholson G; Sereda MW; Seeman P; Kremensky I; Mitev V; De Jonghe P
    Arch Neurol; 2007 May; 64(5):706-13. PubMed ID: 17502470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The R495W mutation in SPG3A causes spastic paraplegia associated with axonal neuropathy.
    Scarano V; Mancini P; Criscuolo C; De Michele G; Rinaldi C; Tucci T; Tessa A; Santorelli FM; Perretti A; Santoro L; Filla A
    J Neurol; 2005 Aug; 252(8):901-3. PubMed ID: 15742100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary spastic paraplegia: identification of an SPG3A gene mutation in a Chinese family.
    Chan KY; Ching CK; Mak CM; Lam CW; Chan AY
    Hong Kong Med J; 2009 Aug; 15(4):304-7. PubMed ID: 19652243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia.
    Muglia M; Magariello A; Nicoletti G; Patitucci A; Gabriele AL; Conforti FL; Mazzei R; Caracciolo M; Ardito B; Lastilla M; Tedeschi G; Quattrone A
    Ann Neurol; 2002 Jun; 51(6):794-5. PubMed ID: 12112092
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia.
    Hedera P; Fenichel GM; Blair M; Haines JL
    Arch Neurol; 2004 Oct; 61(10):1600-3. PubMed ID: 15477516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A SPG3A mutation with a novel foot phenotype of hereditary spastic paraplegia in a Chinese Han family.
    Li XH; Song C; Chen SQ; Zhou Y; Guo H; Zhou CL; Yang ZY; Liang YX; Wang YM
    Chin Med J (Engl); 2007 May; 120(9):834-7. PubMed ID: 17531128
    [No Abstract]   [Full Text] [Related]  

  • 13. Very early onset and severe complicated phenotype caused by a new spastic paraplegia 3A gene mutation.
    Fusco C; Frattini D; Farnetti E; Nicoli D; Casali B; Della Giustina E
    J Child Neurol; 2012 Oct; 27(10):1348-50. PubMed ID: 22378671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset autosomal dominant spastic paraplegia caused by novel mutations in SPG3A.
    Abel A; Fonknechten N; Hofer A; Dürr A; Cruaud C; Voit T; Weissenbach J; Brice A; Klimpe S; Auburger G; Hazan J
    Neurogenetics; 2004 Dec; 5(4):239-43. PubMed ID: 15517445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four novel SPG3A/atlastin mutations identified in autosomal dominant hereditary spastic paraplegia kindreds with intra-familial variability in age of onset and complex phenotype.
    Smith BN; Bevan S; Vance C; Renwick P; Wilkinson P; Proukakis C; Squitieri F; Berardelli A; Warner TT; Reid E; Shaw CE
    Clin Genet; 2009 May; 75(5):485-9. PubMed ID: 19459885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia.
    Wilkinson PA; Hart PE; Patel H; Warner TT; Crosby AH
    J Neurol Sci; 2003 Dec; 216(1):43-5. PubMed ID: 14607301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutation in the ATL1 with autosomal dominant hereditary spastic paraplegia presented as dysautonomia.
    Shin JW; Jung KH; Lee ST; Moon J; Seong MW; Park SS; Lee SK; Chu K
    Auton Neurosci; 2014 Oct; 185():141-3. PubMed ID: 24969372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extremely severe complicated spastic paraplegia 3A with neonatal onset.
    Yonekawa T; Oya Y; Higuchi Y; Hashiguchi A; Takashima H; Sugai K; Sasaki M
    Pediatr Neurol; 2014 Nov; 51(5):726-9. PubMed ID: 25193411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia.
    Battini R; Fogli A; Borghetti D; Michelucci A; Perazza S; Baldinotti F; Conidi ME; Ferreri MI; Simi P; Cioni G
    Eur J Neurol; 2011 Jan; 18(1):150-7. PubMed ID: 20550563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal dopaminergic nigrostriatal innervation in SPG3A hereditary spastic paraplegia.
    Albin RL; Koeppe RA; Rainier S; Fink JK
    J Neurogenet; 2008; 22(4):289-94. PubMed ID: 19085270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.